Your session is about to expire
← Back to Search
Stress Management and Resiliency Training for Depression (SMART-D) Therapy for Depression
Study Summary
This trial is testing if a therapy that helps manage stress and build resiliency will also help treat major depression.
- Depression
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still available for this research endeavor?
"Affirmative. According to the details posted on clinicaltrials.gov, this research study is currently recruiting participants who meet its criteria. It was first initiated on December 18th 2020 and most recently updated on February 10th 2022; with a goal of enrolling 80 individuals across 3 medical centres."
Is there an age limit preventing senior citizens from participating in this research?
"The age requirements to join this trial are between 25 and 80 years old, according to the parameters outlined in its eligibility criteria."
What qualifications must prospective participants satisfy to join this trial?
"This trial seeks to enrol 80 melancholic individuals aged between 25 and 80. Eligibility criteria include: having a diagnosis of major depression from the Mayo Clinic Depression Center, being partially or nearly remitted with PHQ-9 scores ≤14, consenting to audio recording of random group sessions which will be disclosed at the final study session., possessing no co-morbid diagnoses like persistent depressive disorder and generalized anxiety disorders, and continuing taking medications prescribed by their clinical treatment team."
How many volunteers are currently participating in this medical trial?
"Affirmative, the information available on clinicaltrials.gov confirms that enrolment is open for this investigation. Initially posted on December 18th 2020 and most recently updated February 10th 2022, it seeks 80 participants to be sourced from 3 distinct sites."
Share this study with friends
Copy Link
Messenger